April 6, 2016
(The New Yorker) – When the abortion drug mifepristone first became legally available in the U.S., in 2000, it seemed to carry with it the potential for a ceasefire in the abortion wars. Because the pills could be administered in a variety of medical settings, and the abortion itself took place at home, the new regimen offered an alternative to the freestanding clinics that had become flashpoints for protest. So-called medical (as opposed to surgical) abortions could occur earlier in gestation, almost as soon as a woman realized that she was pregnant. Americans had fewer moral qualms about abortions performed at this stage, and women preferred to have them then. The drug seemed to unfurl a vision of the future in which abortion was less politicized, more private, and more seamlessly and matter-of-factly folded into health care.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.